Maintenance of Muscle Mass and Load-Induced Growth in Muscle RING Finger 1 Null Mice with Age.

Departments of Neurobiology, Physiology, and Behavior, University of California, Davis, CA, 95616
Aging cell (Impact Factor: 5.94). 08/2013; DOI: 10.1111/acel.12150
Source: PubMed

ABSTRACT Age-related loss of muscle mass occurs to varying degrees in all individuals and has a detrimental effect on morbidity and mortality. Muscle Ring Finger 1 (MuRF1), a muscle specific E3 ubiquitin ligase, is believed to mediate muscle atrophy through the ubiquitin proteasome system (UPS). Deletion of MuRF1 (KO) in mice attenuates the loss of muscle mass following denervation, disuse and glucocorticoid treatment; however, its role in age-related muscle loss is unknown. In this study, skeletal muscle from male wild type (WT) and MuRF1 KO mice were studied up to the age of 24 months. Muscle mass and fiber cross-sectional area decreased significantly with age in WT, but not KO mice. In aged WT muscle, significant decreases in proteasome activities, especially 20S and 26S β5 (20-40% decrease), were measured and were associated with significant increases in the maladaptive endoplasmic reticulum (ER) stress marker, CHOP. Conversely, in aged MuRF1 KO mice 20S or 26S β5 proteasome activity was maintained or decreased to a lesser extent than in WT mice and no increase in CHOP expression was measured. Examination of the growth response of older (18 months) mice following functional overload, revealed that WT mice had significantly less growth relative to young mice (1.37 vs. 1.83 fold), whereas MuRF1 KO mice had a normal growth response (1.74 vs. 1.90 fold). These data collectively suggest that with age, MuRF1 plays an important role in the control of skeletal muscle mass and growth capacity through the regulation of cellular stress. This article is protected by copyright. All rights reserved.


Available from: Keith Baar, Jun 16, 2015
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: This study assessed and compared acute muscle molecular responses before and after 5 wks training, employing either aerobic (AE) and resistance exercise (RE) or RE only. Ten men performed one-legged RE, while the contralateral limb performed AE followed by RE 6 h later (AE+RE). Before (untrained) and after (trained) the intervention, acute bouts of RE were performed with or without preceding AE. Biopsies were obtained from m. vastus lateralis of each leg PRE and 3 h POST RE to determine mRNA-levels of VEGF, PGC-1α, MuRF-1, atrogin-1, myostatin, and phosphorylation of mTOR, p70S6K, rpS6 and eEF2. PGC-1α and VEGF expression increased (P<0.05) after acute RE in the untrained, but not the trained state. These markers showed greater response after AE+RE than RE in either condition. Myostatin was lower after AE+RE than RE, both before and after training. AE+RE showed higher MuRF-1 and atrogin-1 expression than RE in the untrained, not the trained state. Exercise increased (P<0.05) p70S6K phosphorylation both before and after training, yet this increase tended to be more prominent for AE+RE than RE before training. Phosphorylation of p70S6K was greater in trained muscle. Changes in these markers did not correlate with exercise-induced alterations in strength or muscle size. Concurrent exercise in untrained skeletal muscle prompts global molecular responses consistent with resulting whole-muscle adaptations. Yet, training blunts the more robust anabolic response shown after AE+RE compared with RE. This study challenges the concept that single molecular markers could predict training-induced changes in muscle size or strength. This article is protected by copyright. All rights reserved.
    Acta Physiologica 10/2013; DOI:10.1111/apha.12174 · 4.25 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The regulation of skeletal muscle mass depends on the balance between protein synthesis and degradation. The role of protein degradation and in particular, the ubiquitin proteasome system, and increased expression of the E3 ubiquitin ligases, MuRF1 and MAFbx/atrogin-1, in the regulation of muscle size in response to growth stimuli is unclear. Thus, the aim of this study was to measure both proteasome activity and protein synthesis in mice over a 14-day period of chronic loading using the functional overload (FO) model. Further, the importance of MuRF1 and MAFbx expression in regulating muscle hypertrophy was examined by measuring muscle growth in response to FO in mice with a null deletion (KO) of either MuRF1 or MAFbx. In wild type (WT) mice, the increase in muscle mass correlated with significant increases (2-fold) in protein synthesis at 7 and 14 days. Interestingly, proteasome activity significantly increased in WT mice after one day, and continued to increase, peaking at 7 days following FO. The increase in proteasome activity was correlated with increases in the expression of the Forkhead transcription factors, FOXO1 and FOXO3a, which increased after both MuRF1 and MAFbx increased and returned to baseline. As in WT mice, hypertrophy in the MuRF1 and MAFbx KO mice was associated with significant increases in proteasome activity after 14 days of FO. The increase in plantaris mass was similar between the WT and MuRF1 KO mice following FO, however, muscle growth was significantly reduced in female MAFbx KO mice. Collectively, these results indicate that muscle hypertrophy is associated with increases in both protein synthesis and degradation. Further, MuRF1 or MAFbx expression is not required to increase proteasome activity following increased loading, however, MAFbx expression may be required for proper growth/remodeling of muscle in response to increase loading.
    Frontiers in Physiology 02/2014; 5:69. DOI:10.3389/fphys.2014.00069
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Recent advances in our understanding of the biology of muscle have led to new interest in the pharmacological treatment of muscle wasting. Loss of muscle mass and increased intramuscular fibrosis occur in both sarcopenia and muscular dystrophy. Several regulators (mammalian target of rapamycin, serum response factor, atrogin-1, myostatin, etc.) seem to modulate protein synthesis and degradation or transcription of muscle-specific genes during both sarcopenia and muscular dystrophy. This review provides an overview of the adaptive changes in several regulators of muscle mass in both sarcopenia and muscular dystrophy.
    Frontiers in Aging Neuroscience 08/2014; 6:230. DOI:10.3389/fnagi.2014.00230 · 2.84 Impact Factor